crp: listed yesterday, weak opening

  1. 9 Posts.
    Anybody know anything about CRP? Oversubscribed, but very weak yesterday and much the same today. Few buyers and sellers.

    Axel Ullrich (non-exec director) has had a good track record in the past with biotechs, so it will be interesting to see how these pan out.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.